Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02278458 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | unknown | Phase 1 | 24 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT00176735 | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer | terminated | N/A | — | University of Michigan Rogel Cancer CenterOTHER | 0 | May 20, 2015 | clinicaltrials |
| NCT00743379 |
| Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors |
| completed |
| Phase 1 / Phase 2 |
| 71 |
| Threshold PharmaceuticalsINDUSTRY |
| 1 |
| May 7, 2015 |
| clinicaltrials |
| NCT00474812 | Dasatinib in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT02132403 | (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer(PM-01) | terminated | Phase 1 | 3 | University of Illinois at ChicagoOTHER | 1 | May 1, 2015 | clinicaltrials |
| NCT00006981 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00066651 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00253526 | Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 28, 2015 | clinicaltrials |
| NCT02159248 | Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation | withdrawn | Phase 1 | 0 | Orlando Health, Inc.OTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00238199 | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 25 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT01167738 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer(PACT-17) | terminated | Phase 2 | 60 | IRCCS San RaffaeleOTHER | 1 | Apr 24, 2015 | clinicaltrials |
| NCT02424279 | Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder | unknown | N/A | 90 | Medical University of GdanskOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT00588367 | CT Pancreas Perfusion | completed | — | 30 | Mayo ClinicOTHER | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01587534 | Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) | completed | Phase 2 | 67 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00998322 | A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma | completed | Phase 2 | 34 | Oncolytics BiotechINDUSTRY | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00300950 | Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer | completed | Phase 2 | 176 | GlobeImmuneINDUSTRY | 2 | Apr 6, 2015 | clinicaltrials |
| NCT01094535 | Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery | withdrawn | N/A | 0 | Columbia UniversityOTHER | 1 | Apr 6, 2015 | clinicaltrials |
| NCT02310971 | Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | withdrawn | Phase 2 | 0 | Prima BioMed LtdINDUSTRY | 0 | Apr 3, 2015 | clinicaltrials |
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | completed | Phase 1 / Phase 2 | 25 | Yale UniversityOTHER | 1 | Mar 27, 2015 | clinicaltrials |
| NCT01521702 | NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer(NEOPAC) | completed | Phase 3 | 2 | Institut Paoli-CalmettesOTHER | 1 | Mar 20, 2015 | clinicaltrials |
| NCT01130701 | A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . .(PMABIIS) | withdrawn | Phase 2 | 0 | University of Massachusetts, WorcesterOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT01472198 | A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma | completed | Phase 2 | 250 | Gilead SciencesINDUSTRY | 2 | Mar 10, 2015 | clinicaltrials |
| NCT01608841 | The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib | unknown | Phase 2 | 88 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Feb 18, 2015 | clinicaltrials |
| NCT00652366 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 467 | Hoffmann-La RocheINDUSTRY | 23 | Feb 11, 2015 | clinicaltrials |
| NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer(GIP-2) | unknown | Phase 3 | 310 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01898741 | Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 30 | UMC UtrechtOTHER | 1 | Feb 3, 2015 | clinicaltrials |
| NCT01628458 | Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer(RFA of LAPC) | completed | Phase 2 | 17 | UMC UtrechtOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer(FLAP) | completed | Phase 2 | 50 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Jan 30, 2015 | clinicaltrials |
| NCT00114244 | Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01995084 | In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study(HYPE) | completed | N/A | 32 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT02048943 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer(PROSPECT) | completed | Phase 2 / Phase 3 | 312 | CONKO-StudiengruppeOTHER | 1 | Jan 8, 2015 | clinicaltrials |
| NCT00962312 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 9 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01927393 | Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01694589 | A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | withdrawn | Early Phase 1 | 0 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | unknown | Phase 2 / Phase 3 | 1 | Assiut UniversityOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT01834170 | EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 1 | 12 | University of TehranOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01232829 | Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2014 | clinicaltrials |
| NCT00131911 | Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2014 | clinicaltrials |
| NCT02285660 | Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition | unknown | N/A | — | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Nov 7, 2014 | clinicaltrials |
| NCT01593995 | EGF Ointment for Erlotinib Skin Lesion | completed | Phase 2 | 52 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT02024997 | Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study | completed | Early Phase 1 | 15 | Cedars-Sinai Medical CenterOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT00482625 | Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Oct 16, 2014 | clinicaltrials |
| NCT02260128 | Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery | unknown | N/A | 72 | Michael Bau MortensenOTHER | 1 | Oct 9, 2014 | clinicaltrials |
| NCT00660348 | Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | terminated | N/A | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT01411072 | Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer | unknown | N/A | 20 | AHS Cancer Control AlbertaOTHER | 1 | Oct 3, 2014 | clinicaltrials |
| NCT01586611 | A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer(Panc001) | unknown | Phase 3 | 175 | AHS Cancer Control AlbertaOTHER | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01362582 | Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer(PANUSCO) | terminated | Phase 3 | 32 | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Sep 25, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 22, 2015source: clinicaltrials